Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic destructive non-suppurating cholangitis].

D Müting, R Fischer, J F Kalk

    Fortschritte Der Medizin
    |July 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-term effectiveness of high-dosed ornithine-aspartate on urea synthesis rate and portal hypertension in human liver cirrhosis.

    Amino acids·2013
    Same author

    [Structural quality of oncologic rehabilitation. Viewpoint of the Professional Committee of Rehabilitation, After-care and Social Medicine of the German Cancer Society].

    Die Rehabilitation·2001
    Same author

    [Process quality in oncologic rehabilitation. Viewpoint of the Professional Committee of Rehabilitation, After-care and Social Medicine of the German Cancer Society].

    Die Rehabilitation·2001
    Same author

    [Outcome quality in oncologic rehabilitation. Viewpoint of the Professional Committee of Rehabilitation, After-Care and Social Medicine of the German Cancer Society].

    Die Rehabilitation·2001
    Same author

    Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure.

    Journal of hepatology·1999
    Same author

    Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.

    Hepatology (Baltimore, Md.)·1999
    Same journal

    [More information--less pain. Procedure in pain following amputation of limbs. Brachial plexus injury and nerve root avulsion. Interview by Susanne Kammerer].

    Fortschritte der Medizin·1999
    Same journal

    [Galenic alternatives to unstable tocopherol acetate. "Smeared" or cheated?--Vitamin E in facial ointments].

    Fortschritte der Medizin·1999
    Same journal

    [Gene diagnosis in the hand of the physician].

    Fortschritte der Medizin·1999
    Same journal

    [Is non-toxic cancer therapy through biotechnology a possibility?].

    Fortschritte der Medizin·1999
    Same journal

    [Smoking withdrawal in practice and clinic].

    Fortschritte der Medizin·1999
    Same journal

    [The future of pancreas diagnosis. An exclusive training service of the Gastro-Ligue for dermatologists].

    Fortschritte der Medizin·1999
    See all related articles

    Diagnosing chronic destructive non-suppurative cholangitis (CDNC) early is challenging due to atypical liver morphology. While some treatments offer temporary relief, the long-term prognosis for CDNC remains uncertain.

    Area of Science:

    • Hepatology
    • Gastroenterology
    • Immunology

    Background:

    • Chronic destructive non-suppurative cholangitis (CDNC) presents with atypical initial liver morphology, complicating early diagnosis.
    • Key early symptoms include severe pruritus and elevated IgM, alkaline phosphatase (AP), and gamma-glutamyl transpeptidase (GGT) levels.

    Purpose of the Study:

    • To investigate the diagnostic utility of antimitochondrial antibodies (AMA) in CDNC.
    • To evaluate the effectiveness of various treatment strategies for CDNC.
    • To explore potential improvements in the prognosis of CDNC through early medical intervention.

    Main Methods:

    • Analysis of clinical data from 101 CDNC patients.
    • Monitoring of liver enzyme levels, IgM, and AMA.
    • Assessment of treatment responses to ammonia-reducing amino acids, phenobarbital, cholestyramine, D-penicillamine, prednisolone, and azathioprine.

    Related Experiment Videos

    Main Results:

    • Antimitochondrial antibodies (AMA) were found to appear later than the elevation of key liver enzymes in CDNC patients.
    • A notable observation was the presence of 13 male patients among the 101 studied, particularly in the last three years.
    • Symptomatic treatments like ammonia-reducing agents, phenobarbital, and cholestyramine helped manage pruritus, while dietary modifications (pectin-rich) and probiotics (lactulose, bifidum milk) supported liver function.
    • Specific treatments with prednisolone and azathioprine were disappointing; D-penicillamine showed temporary efficacy but requires cautious use due to side effects, necessitating low doses (100-200 mg/day) combined with Vitamin B6 (300 mg/day).

    Conclusions:

    • Early diagnosis of CDNC remains difficult due to atypical initial liver morphology.
    • Current medical treatments offer symptomatic relief and temporary benefits, but their impact on the overall poor prognosis of CDNC is still uncertain.
    • Further research is needed to determine if early-stage medical interventions can significantly improve the long-term outlook for CDNC patients.